PO-1682 Visibility, artifacts and dose degradations around gold markers in proton therapy of prostate cancer von Stolarczyk, L., Folsted Kallehauge, J., Barbosa Valdetaro, L., Muren, L.P., Høyer, M., Randers, P., Stagaard Johansen, T., Rønde, H.S., Sitarz, M., Tilbæk, S., Vestergaard, A., Bentzenb, L., Elleberg Petersena, S.

Volltext